Canada markets close in 5 hours 20 minutes

First Wave BioPharma, Inc. (FWBI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8400-0.0600 (-2.05%)
As of 10:39AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.77M
Enterprise Value 2.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.60
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.18

Trading Information

Stock Price History

Beta (5Y Monthly) 1.21
52-Week Change 3-94.63%
S&P500 52-Week Change 321.61%
52 Week High 365.0000
52 Week Low 32.7500
50-Day Moving Average 35.1490
200-Day Moving Average 37.1713

Share Statistics

Avg Vol (3 month) 3119.57k
Avg Vol (10 day) 335.72k
Shares Outstanding 52.03M
Implied Shares Outstanding 62.03M
Float 81.91M
% Held by Insiders 17.69%
% Held by Institutions 14.07%
Shares Short (Mar 28, 2024) 455.04k
Short Ratio (Mar 28, 2024) 40.38
Short % of Float (Mar 28, 2024) 42.72%
Short % of Shares Outstanding (Mar 28, 2024) 42.72%
Shares Short (prior month Feb 29, 2024) 430.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Dec 18, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-159.98%
Return on Equity (ttm)-497.87%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.74M
Net Income Avi to Common (ttm)-16.1M
Diluted EPS (ttm)-47.8800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.71M
Total Cash Per Share (mrq)1.83
Total Debt (mrq)826.84k
Total Debt/Equity (mrq)22.95%
Current Ratio (mrq)1.58
Book Value Per Share (mrq)2.31

Cash Flow Statement

Operating Cash Flow (ttm)-12.38M
Levered Free Cash Flow (ttm)-7.76M